These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2770890)

  • 1. Release of 3H-5-hydroxytryptamine by amiflamine and related phenylalkylamines from rat occipital cortex slices.
    Ask AL; Fagervall I; Huang RB; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jun; 339(6):684-9. PubMed ID: 2770890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of amiflamine and related compounds on the accumulation of biogenic monoamines in rat brain slices in vitro and ex vivo in relation to their behavioural effects.
    Rényi L; Ross SB
    Acta Pharmacol Toxicol (Copenh); 1985 May; 56(5):416-26. PubMed ID: 4036634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of 5-hydroxytryptamine accumulation and deamination by substituted phenylalkylamines in hypothalamic synaptosomes from normal and reserpine-pretreated rats.
    Ask AL; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec; 336(6):591-6. PubMed ID: 2965308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of monoamine oxidase inhibitors on the ejaculatory response induced by 5-methoxy-N,N-dimethyltryptamine in the rat.
    Rényi L
    Br J Pharmacol; 1986 Aug; 88(4):827-35. PubMed ID: 3091132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of acute and repeated administration of amiflamine on monoamine oxidase inhibition in the rat.
    Ask AL; Fagervall I; Jonze M; Kelder D; Nygren R; Ross SB
    Biochem Pharmacol; 1984 Sep; 33(18):2839-47. PubMed ID: 6477643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition by amiflamine of monoamine oxidase type A in rat brain, liver and duodenum.
    Ask AL
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):56-63. PubMed ID: 6493351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of monoamine oxidase in monoaminergic neurons in the rat brain.
    Ask AL; Fagervall I; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(2):79-87. PubMed ID: 6646243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of monoamine oxidase A-form and semicarbazide-sensitive amine oxidase by selective and reversible monoamine oxidase-A inhibitors, amiflamine and FLA 788(+).
    Morikawa F; Ueda T; Arai Y; Kinemuchi H
    Pharmacology; 1986; 32(1):38-45. PubMed ID: 3945672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure to detect any transport of the irreversible monoamine oxidase inhibitor N-cyclopropyl-4-chloroamphetamine by the carrier of 5-hydroxytryptamine in the brain of the rat in vivo.
    Fagervall I; Ross SB
    Neuropharmacology; 1986 Aug; 25(8):911-3. PubMed ID: 3490629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased total activity in the rat after L-tryptophan plus the monoamine oxidase-A inhibitor amiflamine but not after L-tryptophan plus clorgyline.
    Archer T; Fowler CJ; Fredriksson A; Lewander T; Magnusson O; Mohringe B; Söderberg U
    Br J Pharmacol; 1985 Jul; 85(3):581-90. PubMed ID: 2411326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of monoamine oxidase in 5-hydroxytryptaminergic neurones by substituted p-aminophenylalkylamines.
    Ask AL; Fagervall I; Florvall L; Ross SB; Ytterborn S
    Br J Pharmacol; 1985 Jul; 85(3):683-90. PubMed ID: 3861206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of repeated amiflamine administration on serotonergic and noradrenergic neurotransmission: electrophysiological studies in the rat CNS.
    Blier P; de Montigny C; Azzaro AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Nov; 334(3):253-60. PubMed ID: 3808082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselective inhibition of monoamine oxidase and semicarbazide-sensitive amine oxidase by 4-dimethylamino-2,alpha-dimethylphenethylamine (FLA 336).
    Fowler CJ; Eriksson M; Thorell G; Magnusson O
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct; 327(4):279-84. PubMed ID: 6514012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of the A form of monoamine oxidase by 4-dimethylamino-alpha-methylphenylalkylamine derivatives in the rat.
    Ask AL; Hellström W; Norrman S; Ogren SO; Ross SB
    Neuropharmacology; 1982 Apr; 21(4):299-308. PubMed ID: 7088264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (+)-4-Dimethylamino-2,alpha-dimethylphenethylamine (FLA 336(+)), a selective inhibitor of the A form of monoamine oxidase in the rat brain.
    Ask AL; Högberg K; Schmidt L; Kiessling H; Ross SB
    Biochem Pharmacol; 1982 Apr; 31(7):1401-6. PubMed ID: 7092929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of 5-HT release in the guinea-pig brain following long-term administration of antidepressant drugs.
    Blier P; Bouchard C
    Br J Pharmacol; 1994 Oct; 113(2):485-95. PubMed ID: 7834200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanism by which monoamine oxidase inhibitors give rise to a non-calcium-dependent component in the depolarization-induced release of 5-HT from rat brain synaptosomes.
    Evans SM; Collard KJ
    Br J Pharmacol; 1988 Nov; 95(3):950-6. PubMed ID: 3264736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine.
    Crespi D; Mennini T; Gobbi M
    Br J Pharmacol; 1997 Aug; 121(8):1735-43. PubMed ID: 9283711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro effects on monoamine uptake and release by the reversible monoamine oxidase-B inhibitors lazabemide and N-(2-aminoethyl)-p-chlorobenzamide: a comparison with L-deprenyl.
    Bondiolotti GP; Galva MD; Villa F; Sciaba L; Picotti GB
    Biochem Pharmacol; 1995 Jun; 50(1):97-102. PubMed ID: 7605351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of monoamine oxidase by p-aminosubstituted phenylalkylamines in catecholaminergic neurones.
    Ask AL; Fagervall I; Florvall L; Ross SB; Ytterborn S
    Neuropharmacology; 1986 Jan; 25(1):33-40. PubMed ID: 3005903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.